ATE292475T1 - Abgabesystem für ein mittel gegen schuppen - Google Patents

Abgabesystem für ein mittel gegen schuppen

Info

Publication number
ATE292475T1
ATE292475T1 AT00965903T AT00965903T ATE292475T1 AT E292475 T1 ATE292475 T1 AT E292475T1 AT 00965903 T AT00965903 T AT 00965903T AT 00965903 T AT00965903 T AT 00965903T AT E292475 T1 ATE292475 T1 AT E292475T1
Authority
AT
Austria
Prior art keywords
malassezia furfur
delivery system
active agent
binding specifically
antibody
Prior art date
Application number
AT00965903T
Other languages
English (en)
Inventor
Leo G J Frenken
Der Vaart Jan M Van
Original Assignee
Unilever Nv
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Unilever Nv filed Critical Unilever Nv
Application granted granted Critical
Publication of ATE292475T1 publication Critical patent/ATE292475T1/de

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61Q—SPECIFIC USE OF COSMETICS OR SIMILAR TOILETRY PREPARATIONS
    • A61Q5/00—Preparations for care of the hair
    • A61Q5/006—Antidandruff preparations
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K8/00—Cosmetics or similar toiletry preparations
    • A61K8/18—Cosmetics or similar toiletry preparations characterised by the composition
    • A61K8/30—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds
    • A61K8/64—Proteins; Peptides; Derivatives or degradation products thereof
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K8/00—Cosmetics or similar toiletry preparations
    • A61K8/18—Cosmetics or similar toiletry preparations characterised by the composition
    • A61K8/30—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds
    • A61K8/64—Proteins; Peptides; Derivatives or degradation products thereof
    • A61K8/66—Enzymes
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P17/00—Drugs for dermatological disorders
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P17/00—Drugs for dermatological disorders
    • A61P17/08—Antiseborrheics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61Q—SPECIFIC USE OF COSMETICS OR SIMILAR TOILETRY PREPARATIONS
    • A61Q5/00—Preparations for care of the hair
    • A61Q5/02—Preparations for cleaning the hair
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K16/00—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies
    • C07K16/14—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material from fungi, algea or lichens
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K2039/505—Medicinal preparations containing antigens or antibodies comprising antibodies
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K2800/00—Properties of cosmetic compositions or active ingredients thereof or formulation aids used therein and process related aspects
    • A61K2800/40—Chemical, physico-chemical or functional or structural properties of particular ingredients
    • A61K2800/57—Compounds covalently linked to a(n inert) carrier molecule, e.g. conjugates, pro-fragrances
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K2800/00—Properties of cosmetic compositions or active ingredients thereof or formulation aids used therein and process related aspects
    • A61K2800/70—Biological properties of the composition as a whole
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K2800/00—Properties of cosmetic compositions or active ingredients thereof or formulation aids used therein and process related aspects
    • A61K2800/80—Process related aspects concerning the preparation of the cosmetic composition or the storage or application thereof
    • A61K2800/86—Products or compounds obtained by genetic engineering
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K2317/00—Immunoglobulins specific features
    • C07K2317/20—Immunoglobulins specific features characterized by taxonomic origin
    • C07K2317/22—Immunoglobulins specific features characterized by taxonomic origin from camelids, e.g. camel, llama or dromedary

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Medicinal Chemistry (AREA)
  • Engineering & Computer Science (AREA)
  • Dermatology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Epidemiology (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Birds (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Molecular Biology (AREA)
  • Biophysics (AREA)
  • Genetics & Genomics (AREA)
  • Immunology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Biochemistry (AREA)
  • Cosmetics (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Peptides Or Proteins (AREA)
  • Paper (AREA)
  • Non-Reversible Transmitting Devices (AREA)
  • Cephalosporin Compounds (AREA)
  • Feed For Specific Animals (AREA)
  • Saccharide Compounds (AREA)
AT00965903T 1999-09-16 2000-08-28 Abgabesystem für ein mittel gegen schuppen ATE292475T1 (de)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
EP99307356 1999-09-16
PCT/EP2000/008380 WO2001019871A2 (en) 1999-09-16 2000-08-28 Delivery system for antidandruff agent

Publications (1)

Publication Number Publication Date
ATE292475T1 true ATE292475T1 (de) 2005-04-15

Family

ID=8241623

Family Applications (1)

Application Number Title Priority Date Filing Date
AT00965903T ATE292475T1 (de) 1999-09-16 2000-08-28 Abgabesystem für ein mittel gegen schuppen

Country Status (6)

Country Link
EP (1) EP1212100B1 (de)
JP (1) JP2003509438A (de)
AT (1) ATE292475T1 (de)
AU (1) AU7648900A (de)
DE (1) DE60019309T2 (de)
WO (1) WO2001019871A2 (de)

Families Citing this family (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
KR100446856B1 (ko) * 2001-04-14 2004-09-04 주식회사 콧데 항비듬균 면역항체와 그 용도
WO2004041865A2 (en) 2002-11-08 2004-05-21 Ablynx N.V. Stabilized single domain antibodies
AU2003286004A1 (en) * 2002-11-08 2004-06-07 Ablynx N.V. Single domain antibodies directed against interferon- gamma and uses therefor
US9320792B2 (en) 2002-11-08 2016-04-26 Ablynx N.V. Pulmonary administration of immunoglobulin single variable domains and constructs thereof
US20060034845A1 (en) 2002-11-08 2006-02-16 Karen Silence Single domain antibodies directed against tumor necrosis factor alpha and uses therefor
CA2524710C (en) * 2003-05-14 2012-07-31 Dow Corning Corporation Controlled release of active agents utilizing repeat sequence protein polymers
CN115089516A (zh) * 2022-07-22 2022-09-23 中植(山东)生物技术有限责任公司 一种具备去屑止痒功效的复方植物提取物及其制备方法

Family Cites Families (12)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
AU642980B2 (en) * 1990-03-21 1993-11-04 Quest International B.V. Ultilization of enzymes
GB9021671D0 (en) * 1990-10-05 1990-11-21 Unilever Plc Delivery of agents
AU641736B2 (en) * 1990-03-21 1993-09-30 Quest International B.V. Delivery of agents
JP2953529B2 (ja) * 1990-05-25 1999-09-27 寶酒造株式会社 新規化粧料
AU652778B2 (en) * 1990-10-15 1994-09-08 Quest International B.V. Treatment composition
GB9208339D0 (en) * 1992-04-15 1992-06-03 Unilever Plc Treatment composition
WO1994004678A1 (en) * 1992-08-21 1994-03-03 Casterman Cecile Immunoglobulins devoid of light chains
JPH1077296A (ja) * 1996-09-05 1998-03-24 Takara Shuzo Co Ltd 組換えマラセチア抗原性蛋白質並びにその遺伝子
DE69717206D1 (de) * 1996-08-13 2003-01-02 Quest Int Hemmung oder Reduzierung des Mundgeruches
JPH1129489A (ja) * 1997-05-10 1999-02-02 Nomura:Kk 抗フケ菌剤
JPH11206379A (ja) * 1998-01-28 1999-08-03 Takara Shuzo Co Ltd マラセチア由来抗原性ポリペプチド
BR0009947A (pt) * 1999-04-23 2002-12-31 St Jude Medical Conjugado antimicrobiano, método de eliminar microorganismos viáveis, dispositivo médico, e, método de formar um conjugado antimicrobiano

Also Published As

Publication number Publication date
DE60019309D1 (de) 2005-05-12
EP1212100A2 (de) 2002-06-12
JP2003509438A (ja) 2003-03-11
WO2001019871A3 (en) 2001-06-21
EP1212100B1 (de) 2005-04-06
WO2001019871A2 (en) 2001-03-22
AU7648900A (en) 2001-04-17
DE60019309T2 (de) 2005-09-22

Similar Documents

Publication Publication Date Title
WO2000056774A8 (en) Methods of using bioelastomers
CY1107628T1 (el) Ανθρωπινα ctla-4 αντισωματα και χρησεις αυτων
EA200800952A1 (ru) Конъюгаты антитело-лекарство и способы применения
CA2413190A1 (en) Methods for treating rheumatic diseases using a soluble ctla4 molecule
EA200200105A1 (ru) СОЕДИНЕНИЯ, МОДУЛИРУЮЩИЕ АКТИВНОСТЬ PPARγ;
EA200300293A1 (ru) Противовоспалительные конденсированные пирролокарбазолы
WO2008134724A3 (en) Methods for administering anti-il-5 antibodies
WO2005074607A3 (en) Method of treating hemolytic disease
CY1112993T1 (el) Παραγοντες ειδικης δεσμευσης της αγγειοποιητινης-2 και της αγγειοποιητινης-1
DE60017287D1 (de) Spezifische anonisten für peripherische cannabinoid-rezeptoren
BR0209689A (pt) Uso de fragmento de hmg como agente anti-inflamatório
NO20035301D0 (no) Små molekyl¶re antagonister av proteiner i BCL-2-familien
DK1242115T3 (da) Kemisk programmerbar immunitet
ATE296105T1 (de) Iminbildende polysaccharide, deren herstellung und verwendung als zusatzmittel und immunstimulierende mittel
WO2004091370A3 (en) Method for stimulating angiogenesis and wound healing
CY1109817T1 (el) Ολιγο-βητα-(1,3)-γλυκανη και μονοκλωνικα αντισωματα εναντιον καρκινου
EA200700876A1 (ru) Агенты, специфически связывающие ангиопоэтин-2
WO2008077956A3 (en) Oligonucleotide-, protein and/or peptide-polymer conjugates
ATE292475T1 (de) Abgabesystem für ein mittel gegen schuppen
BR0110208A (pt) Composições e terapias para distúrbios associados com hiperlipidemia
BRPI0507987A (pt) métodos e compostos moduladores receptor de glicocorticóide
ATE304709T1 (de) Substanzen mit verzweigten linkermolekülen
WO2007149586A3 (en) Anti-c35 antibodies for treating cancer
DE69921486D1 (de) Dextran-leptin konjugate, pharmazeutische zusammentsetzungen und verbundene verfahren
AU2003215381A1 (en) EGFRvIII SPECIFIC MONOCLONAL ANTIBODY AND EGFRvIII RIBOZYMES AND USE TO DETECT, TREAT OR PREVENT EGFRvIII ASSOCIATED CANCER

Legal Events

Date Code Title Description
RER Ceased as to paragraph 5 lit. 3 law introducing patent treaties